Arbutus Biopharma Corporation Common Stock (ABUS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ABUS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 169 institutions reported holding ABUS, with 140.6 million shares worth $674.8 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Two Seas Capital | 19,095,583 | $92M | INCREASED |
| Morgan Stanley | 17,698,305 | $85M | DECREASED |
| Whitefort Capital Management | 15,794,261 | $76M | INCREASED |
| BlackRock | 13,766,071 | $66M | INCREASED |
| Vanguard | 9,874,237 | $47M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Arbutus Biopharma Corporation Common Stock on SentiSense.